Manipal Health Enterprises IPO Day 2: GMP holds at 2%, Subscription reaches 15%. Should you Subscribe or Skip?
Manipal Health Enterprises' large IPO is experiencing cautious investor interest on its second day. The grey market premium remains modest, indicating a subdued market sentiment. The company plans to use significant funds for debt repayment and strategic acquisitions. Brokerages largely view Manipal Health's long-term prospects positively, despite premium valuations. The IPO's share allotment is expected in early August 2026.
Read the full story at Markets-Economic Times →